Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Withdrawal Double-blind Study of Etanercept Monotherapy Compared to Methotrexate Monotherapy for Maintenance of Remission in Subjects With Rheumatoid Arthritis

NCT02373813 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT02373813
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02373813 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Withdrawal Double-blind Study of Etanercept Monotherapy Compared to Methotrexate Monotherapy for Maintenance of Remission in Subjects With Rheumatoid Arthritis
Lead sponsor
Amgen
Phase
Phase 3
Overall status
Completed
Start date
February 20, 2015
Completion date
December 6, 2019
Enrollment
371 (actual)
Sites
136

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis